Condition
Hematologic Disease and Disorders
Total Trials
4
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Recruiting3
Enrolling By Invitation1
Clinical Trials (4)
Showing 4 of 4 trials
NCT00001620Enrolling By InvitationPrimary
Screening for Hematology Branch Protocols
NCT07075185Phase 1Recruiting
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
NCT06828796Phase 2RecruitingPrimary
Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
NCT07313059Recruiting
CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research
Showing all 4 trials